首页 > 最新文献

生殖医学杂志最新文献

英文 中文
Vaginal Progesterone Gel for Luteal Support After Cleavage Stage Embryo Transfer: Once or Twice a Day? 阴道黄体酮凝胶用于卵裂期胚胎移植后黄体支持:一天一次还是两次?
IF 0.2 4区 医学 Q4 Medicine Pub Date : 2017-01-01
Bulent Urman, Serdar Celik, Kayhan Yakin, Ebru Alper, Basak Balaban, Baris Ata

OBJECTIVE: To determine whether twice daily dosing of progesterone vaginal gel (PVG) is better for luteal phase support (LPS) than once daily dosing.STUDY DESIGN: Retrospective study including 456 women aged ≤42 years who underwent assisted reproductive technology with long GnRH agonist protocol. Blastocyst transfers and difficult embryo transfers were excluded. LPS was started with 90 mg PVG once daily on the evening of oocyte retrieval and continued until negative pregnancy test or 10th week of pregnancy in both groups. PVG dosage was doubled on the day of embryo transfer in the twice-daily group.RESULTS: Age, duration of infertility, and number of oocytes collected were similar. Numbers of embryos transferred were 2.9 and 2.8 in the once-daily and twice-daily groups, respectively (p=0.04). Embryo implantation (23.96% vs. 27.95%) and clinical pregnancy (50.9% vs. 56.5%) rates favored twice-daily dosage; however, differences were statistically nonsignificant, and the study had 20% power to demonstrate significance. When our results were pooled with a prior trial comparing once and twice daily dosing, twice daily dosing seemed to significantly increase clinical pregnancy rate (rate ratio: 1.18, 95% CI 1.01-1.38).CONCLUSION: Trends favoring twice daily dosing are encouraging findingsand require further investigation.

目的:确定每日两次给药的孕酮阴道凝胶(PVG)是否优于每日一次给药的黄体期支持(LPS)。研究设计:回顾性研究包括456名年龄≤42岁的妇女,她们接受了长期GnRH激动剂方案的辅助生殖技术。排除囊胚移植和困难的胚胎移植。两组患者在卵母细胞回收当晚以90mg PVG开始LPS治疗,每日1次,持续至妊娠试验阴性或妊娠第10周。每日两次组PVG剂量在胚胎移植当天增加一倍。结果:年龄、不孕症持续时间、收集的卵母细胞数量相似。每日1次组和每日2次组的移植胚胎数分别为2.9个和2.8个(p=0.04)。胚胎着床率(23.96% vs. 27.95%)和临床妊娠率(50.9% vs. 56.5%)倾向于每日两次剂量;然而,差异在统计学上不显著,该研究有20%的能力证明显著性。当我们的结果与先前比较每日一次和两次给药的试验合并时,每日两次给药似乎显著增加临床妊娠率(比率比:1.18,95% CI 1.01-1.38)。结论:倾向于每日两次给药的趋势是令人鼓舞的发现,需要进一步调查。
{"title":"Vaginal Progesterone Gel for Luteal Support After Cleavage Stage Embryo Transfer: Once or Twice a Day?","authors":"Bulent Urman,&nbsp;Serdar Celik,&nbsp;Kayhan Yakin,&nbsp;Ebru Alper,&nbsp;Basak Balaban,&nbsp;Baris Ata","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>OBJECTIVE: To determine whether twice daily dosing of progesterone vaginal gel (PVG) is better for luteal phase support (LPS) than once daily dosing.\u0000\u0000STUDY DESIGN: Retrospective study including 456 women aged ≤42 years who underwent assisted reproductive technology with long GnRH agonist protocol. Blastocyst transfers and difficult embryo transfers were excluded. LPS was started with 90 mg PVG once daily on the evening of oocyte retrieval and continued until negative pregnancy test or 10th week of pregnancy in both groups. PVG dosage was doubled on the day of embryo transfer in the twice-daily group.\u0000\u0000RESULTS: Age, duration of infertility, and number of oocytes collected were similar. Numbers of embryos transferred were 2.9 and 2.8 in the once-daily and twice-daily groups, respectively (p=0.04). Embryo implantation (23.96% vs. 27.95%) and clinical pregnancy (50.9% vs. 56.5%) rates favored twice-daily dosage; however, differences were statistically nonsignificant, and the study had 20% power to demonstrate significance. When our results were pooled with a prior trial comparing once and twice daily dosing, twice daily dosing seemed to significantly increase clinical pregnancy rate (rate ratio: 1.18, 95% CI 1.01-1.38).\u0000\u0000CONCLUSION: Trends favoring twice daily dosing are encouraging findings\u0000and require further investigation.</p>","PeriodicalId":50063,"journal":{"name":"生殖医学杂志","volume":"62 1-2","pages":"60-4"},"PeriodicalIF":0.2,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36307846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Septic Shock and Multiple Organ Failure After Office Endometrial Sampling. 办公室子宫内膜取样后脓毒性休克和多器官衰竭。
IF 0.2 4区 医学 Q4 Medicine Pub Date : 2017-01-01
Ahmed Namazov, Joseph Mishal, Eyal E Anteby, Ofer Gemer

BACKGROUND: Office endometrial biopsy with a Pipelle cannula is the main method for sampling the endometrial lining. The Pipelle biopsy is safe, efficient, and cost effective. This office endometrial sampling method is also an accurate and safe procedure for endometrial sampling of patients with endometrial carcinoma. It is associated with minimal pain and does not require anesthesia.CASE: Pipelle is the most common method used for sampling the endometrial lining. No data are available of infectious complications related to endometrial biopsy. The incidence is presumed to be negligible. We present an unusual case of a 52-year-old woman who experienced septic shock and multiple organ failure following Pipelle endometrial sampling.CONCLUSION: Lower abdominal pain is the cardinal presenting symptom in woman with pelvic infection. Our case emphasizes that an atypical symptom such as abdominal pain after endometrial biopsy could be a sign of infectious complications.

背景:办公室子宫内膜活检与管道套管是取样子宫内膜的主要方法。Pipelle活检安全、高效、经济。这种办公室子宫内膜取样方法也是子宫内膜癌患者子宫内膜取样的一种准确和安全的方法。它与最小的疼痛有关,不需要麻醉。病例:管道是子宫内膜取样最常用的方法。目前尚无与子宫内膜活检相关的感染性并发症的资料。据推测,这种发病率可以忽略不计。我们提出一个不寻常的情况下,52岁的妇女谁经历感染性休克和多器官功能衰竭后管道子宫内膜取样。结论:下腹痛是女性盆腔感染的主要症状。本病例强调,子宫内膜活检后出现腹痛等非典型症状可能是感染并发症的征兆。
{"title":"Septic Shock and Multiple Organ Failure After Office Endometrial Sampling.","authors":"Ahmed Namazov,&nbsp;Joseph Mishal,&nbsp;Eyal E Anteby,&nbsp;Ofer Gemer","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>BACKGROUND: Office endometrial biopsy with a Pipelle cannula is the main method for sampling the endometrial lining. The Pipelle biopsy is safe, efficient, and cost effective. This office endometrial sampling method is also an accurate and safe procedure for endometrial sampling of patients with endometrial carcinoma. It is associated with minimal pain and does not require anesthesia.\u0000\u0000CASE: Pipelle is the most common method used for sampling the endometrial lining. No data are available of infectious complications related to endometrial biopsy. The incidence is presumed to be negligible. We present an unusual case of a 52-year-old woman who experienced septic shock and multiple organ failure following Pipelle endometrial sampling.\u0000\u0000CONCLUSION: Lower abdominal pain is the cardinal presenting symptom in woman with pelvic infection. Our case emphasizes that an atypical symptom such as abdominal pain after endometrial biopsy could be a sign of infectious complications.</p>","PeriodicalId":50063,"journal":{"name":"生殖医学杂志","volume":"62 1-2","pages":"72-4"},"PeriodicalIF":0.2,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36307847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paraurethral Leiomyoma. 尿道旁平滑肌瘤群。
IF 0.2 4区 医学 Q4 Medicine Pub Date : 2017-01-01
Serpil Aydogmus, Huseyin Aydogmus, Emre Ekmekci, Sefa Keleckci, Serenat Eris

BACKGROUND: Paraurethral vaginal leiomyoma is a rare and solid tumor of unknown etiology. We present a case of successfully treated paraurethral leiomyoma.CASE: A 49-year old woman, G4P2A2, was admitted to our clinic with complaints of vaginal mass and dyspareunia. During pelvic examination a 4x4-cm-sized, solid mass with hard consistency was detected at the paraurethral area in the front wall of the vagina. In the histopathological examination the mass was found to be compatible with leiomyoma.CONCLUSION: Paraurethral leiomyoma is a rare, hormone-dependent, benign tumor of mesenchymal origin. Surgical excision is necessary for discrimination from sarcoma. One should be cautious of urethral injury during the excision.

背景:阴道尿道旁平滑肌瘤是一种罕见的实体瘤,病因不明。我们报告一例成功治疗的尿道旁平滑肌瘤。病例:一名49岁女性,G4P2A2,因阴道肿块和性交困难而入院。盆腔检查时,在阴道前壁尿道旁区发现一4x4 cm大小、硬稠度的实性肿块。在组织病理学检查中发现肿块与平滑肌瘤一致。结论:尿道旁平滑肌瘤是一种罕见的激素依赖性间质良性肿瘤。手术切除是鉴别肉瘤的必要手段。在切除过程中要小心尿道损伤。
{"title":"Paraurethral Leiomyoma.","authors":"Serpil Aydogmus,&nbsp;Huseyin Aydogmus,&nbsp;Emre Ekmekci,&nbsp;Sefa Keleckci,&nbsp;Serenat Eris","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>BACKGROUND: Paraurethral vaginal leiomyoma is a rare and solid tumor of unknown etiology. We present a case of successfully treated paraurethral leiomyoma.\u0000\u0000CASE: A 49-year old woman, G4P2A2, was admitted to our clinic with complaints of vaginal mass and dyspareunia. During pelvic examination a 4x4-cm-sized, solid mass with hard consistency was detected at the paraurethral area in the front wall of the vagina. In the histopathological examination the mass was found to be compatible with leiomyoma.\u0000\u0000CONCLUSION: Paraurethral leiomyoma is a rare, hormone-dependent, benign tumor of mesenchymal origin. Surgical excision is necessary for discrimination from sarcoma. One should be cautious of urethral injury during the excision.</p>","PeriodicalId":50063,"journal":{"name":"生殖医学杂志","volume":"62 1-2","pages":"85-8"},"PeriodicalIF":0.2,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36308281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Attributes That Fellowship Directors Value in the Selection of Reproductive Endocrinology and Infertility Fellows. 在选择生殖内分泌学和不孕症研究员时,奖学金主任所看重的属性。
IF 0.2 4区 医学 Q4 Medicine Pub Date : 2017-01-01
Amy Kaing, Anupama S Q Kathiresan, Daniel Dumesic, Mousa Shamonki

OBJECTIVE: To investigate which attributes of reproductive endocrinology and infertility (REI) fellowship applicants are most valued by fellowship program directors during the match process.STUDY DESIGN: An electronic survey was administered to determine characteristics most favored by program directors in the selection of REI fellows. A 5-point Likert scale was utilized to rank characteristics, with 1 being "most important" and 5 being" least important." The main outcome measures were factors desired by REI fellowship directors.RESULTS: The overall response rate was 61%. Objective factors that ranked highly were training at a competitive obstetrics and gynecology (OB/GYN) residency program, and clinical or basic science research experience. First authorship research ranked favorably regardless of whether it was in the form of a peer-reviewed paper, oral presentation, or poster abstract. Personal interview and perceived ability to work well with others were subjective factors considered favorably by REI fellowship directors.CONCLUSION: When selecting REI fellows for interviews, fellowship directors value candidates who have trained at competitive OB/GYN residency programs, who have clinical or basic science research experience, and who have contributed to scientific literature as first author. When subsequently ranking fellowship applicants, however, the most important factors are those found in the interview process, such as identification as a "team player".

目的:探讨生殖内分泌与不孕症(REI)奖学金申请人在匹配过程中最受奖学金项目主任重视的属性。研究设计:通过一项电子调查来确定项目主管在选择REI研究员时最喜欢的特征。采用李克特5分量表对特征进行排序,1为“最重要”,5为“最不重要”。主要的结果测量是REI奖学金主任所期望的因素。结果:总有效率为61%。客观因素排名靠前的是在竞争激烈的妇产科(OB/GYN)住院医师项目接受过培训,以及临床或基础科学研究经验。无论是同行评议的论文、口头报告还是海报摘要,第一作者的研究都排名靠前。个人面试和感知到的与他人良好合作的能力是REI奖学金主任认为有利的主观因素。结论:在选择REI研究员进行面试时,奖学金主任更看重那些在竞争激烈的妇产科住院医师项目中接受过培训的候选人,那些有临床或基础科学研究经验的候选人,以及那些以第一作者身份为科学文献做出贡献的候选人。然而,在随后对奖学金申请者进行排名时,最重要的因素是在面试过程中发现的那些因素,比如“团队合作精神”。
{"title":"Attributes That Fellowship Directors Value in the Selection of Reproductive Endocrinology and Infertility Fellows.","authors":"Amy Kaing,&nbsp;Anupama S Q Kathiresan,&nbsp;Daniel Dumesic,&nbsp;Mousa Shamonki","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>OBJECTIVE: To investigate which attributes of reproductive endocrinology and infertility (REI) fellowship applicants are most valued by fellowship program directors during the match process.\u0000\u0000STUDY DESIGN: An electronic survey was administered to determine characteristics most favored by program directors in the selection of REI fellows. A 5-point Likert scale was utilized to rank characteristics, with 1 being \"most important\" and 5 being\" least important.\" The main outcome measures were factors desired by REI fellowship directors.\u0000\u0000RESULTS: The overall response rate was 61%. Objective factors that ranked highly were training at a competitive obstetrics and gynecology (OB/GYN) residency program, and clinical or basic science research experience. First authorship research ranked favorably regardless of whether it was in the form of a peer-reviewed paper, oral presentation, or poster abstract. Personal interview and perceived ability to work well with others were subjective factors considered favorably by REI fellowship directors.\u0000\u0000CONCLUSION: When selecting REI fellows for interviews, fellowship directors value candidates who have trained at competitive OB/GYN residency programs, who have clinical or basic science research experience, and who have contributed to scientific literature as first author. When subsequently ranking fellowship applicants, however, the most important factors are those found in the interview process, such as identification as a \"team player\".</p>","PeriodicalId":50063,"journal":{"name":"生殖医学杂志","volume":"62 1-2","pages":"31-6"},"PeriodicalIF":0.2,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36305812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Perspectives of Obstetrician-Gynecologists as Primary Care Providers. 作为初级保健提供者的妇产科医生的患者观点。
IF 0.2 4区 医学 Q4 Medicine Pub Date : 2017-01-01
Sara Mazzoni, Sarah Brewer, Josh Durfee, Jennifer Pyrzanowski, Juliana Barnard, Amanda F Dempsey, Sean T O'Leary

Objective: To examine women�s perceptions of their obstetrician/gynecologist (ob-gyn) as primary care provider (PCP) and comfort in receiving primary care services in an ob-gyn setting.

Study design: Survey regarding women�s use of their ob-gyn provider as a PCP, their desire and comfort in receiving primary care services from them, and their perceptions of their ob-gyn�s delivery of primary care. Associations were assessed between use of an ob-gyn as PCP and various demographic and attitudinal factors, as well as patients� perceptions of primary care performance

Results: The response rate was 48% (1,404/2,916). Overall, the majority of participants responded that routine primary care services are available at their ob-gyn office and that they were comfortable receiving those services from their ob-gyn. Twenty percent of respondents considered their ob-gyn as their PCP, 52% considered another provider their PCP, and 28% of women did not identify a PCP. Women who were pregnant, mothers of newborns, and patients without a chronic health condition were more likely to identify their ob-gyn as their PCP.

Conclusion: A substantial proportion of women consider their ob-gyn their primary care provider and do not visit another provider regularly. While ob-gyns may not consider themselves as PCPs, they are often perceived as such by patients.

目的:调查妇女对其产科医生/妇科医生(ob-gyn)作为初级保健提供者(PCP)的看法以及在妇产科环境中接受初级保健服务的舒适度。研究设计:调查妇女使用其妇产科医生作为PCP的情况,她们从他们那里接受初级保健服务的愿望和舒适度,以及她们对其妇产科医生提供初级保健服务的看法。评估了使用妇产科医生作为PCP与各种人口统计学和态度因素以及患者对初级保健表现的看法之间的关系。结果:反应率为48%(1,404/2,916)。总体而言,大多数参与者回答说,他们的妇产科办公室可以提供常规的初级保健服务,并且他们从妇产科那里接受这些服务感到舒适。20%的受访者认为他们的妇产科医生是他们的PCP, 52%的人认为其他提供者是他们的PCP, 28%的女性没有确定PCP。孕妇、新生儿的母亲和没有慢性疾病的患者更有可能将自己的妇产科医生视为自己的PCP。结论:相当大比例的妇女认为她们的妇产科医生是她们的初级保健提供者,并且不定期去看其他提供者。虽然妇产科医生可能不认为自己是pcp,但他们经常被患者视为pcp。
{"title":"Patient Perspectives of Obstetrician-Gynecologists as Primary Care Providers.","authors":"Sara Mazzoni,&nbsp;Sarah Brewer,&nbsp;Josh Durfee,&nbsp;Jennifer Pyrzanowski,&nbsp;Juliana Barnard,&nbsp;Amanda F Dempsey,&nbsp;Sean T O'Leary","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To examine women�s perceptions of their obstetrician/gynecologist (ob-gyn) as primary care provider (PCP) and comfort in receiving primary care services in an ob-gyn setting.</p><p><strong>Study design: </strong>Survey regarding women�s use of their ob-gyn provider as a PCP, their desire and comfort in receiving primary care services from them, and their perceptions of their ob-gyn�s delivery of primary care. Associations were assessed between use of an ob-gyn as PCP and various demographic and attitudinal factors, as well as patients� perceptions of primary care performance</p><p><strong>Results: </strong>The response rate was 48% (1,404/2,916). Overall, the majority of participants responded that routine primary care services are available at their ob-gyn office and that they were comfortable receiving those services from their ob-gyn. Twenty percent of respondents considered their ob-gyn as their PCP, 52% considered another provider their PCP, and 28% of women did not identify a PCP. Women who were pregnant, mothers of newborns, and patients without a chronic health condition were more likely to identify their ob-gyn as their PCP.</p><p><strong>Conclusion: </strong>A substantial proportion of women consider their ob-gyn their primary care provider and do not visit another provider regularly. While ob-gyns may not consider themselves as PCPs, they are often perceived as such by patients.</p>","PeriodicalId":50063,"journal":{"name":"生殖医学杂志","volume":"62 1-2","pages":"3-8"},"PeriodicalIF":0.2,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36306914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mirror Syndrome Associated with 18p Deletion Syndrome. 镜像综合征与18p缺失综合征相关。
IF 0.2 4区 医学 Q4 Medicine Pub Date : 2017-01-01
Hyojin Chae, Myungshin Kim, Sa Jin Kim, Min Jeong Kim

BACKGROUND: Mirror syndrome is defined as the development of maternal edema in association with fetal hydrops. This rare disease is called mirror syndrome due to the presence of maternal edema that "mirrors" the fetal and placental condition.CASE: We report the first case of mirror syndrome associated with 18p deletion.CONCLUSION: Cytogenetic analysis should be considered in mirror syndrome to identify the underlying cause.

背景:镜像综合征被定义为与胎儿水肿相关的母体水肿。这种罕见的疾病被称为镜像综合征,因为母体水肿的存在“反映”了胎儿和胎盘的状况。病例:我们报告了第一例与18p缺失相关的镜像综合征。结论:镜像综合征应考虑细胞遗传学分析,以确定根本原因。
{"title":"Mirror Syndrome Associated with 18p Deletion Syndrome.","authors":"Hyojin Chae,&nbsp;Myungshin Kim,&nbsp;Sa Jin Kim,&nbsp;Min Jeong Kim","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>BACKGROUND: Mirror syndrome is defined as the development of maternal edema in association with fetal hydrops. This rare disease is called mirror syndrome due to the presence of maternal edema that \"mirrors\" the fetal and placental condition.\u0000\u0000CASE: We report the first case of mirror syndrome associated with 18p deletion.\u0000\u0000CONCLUSION: Cytogenetic analysis should be considered in mirror syndrome to identify the underlying cause.</p>","PeriodicalId":50063,"journal":{"name":"生殖医学杂志","volume":"62 1-2","pages":"75-8"},"PeriodicalIF":0.2,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36308278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do Different Modes of Labor Induction Affect the Overall Success and Risk of Trial of Labor After Cesarean Section? 不同引产方式对剖宫产术后试产成功率和风险的影响?
IF 0.2 4区 医学 Q4 Medicine Pub Date : 2017-01-01
Heidi K Leftwich, Weihua Gao, Judith U Hibbard

OBJECTIVE: To determine whether different modes of labor induction impact the success rate and perinatal morbidity in women undergoing trial of labor after cesarean (TOLAC).STUDY DESIGN: Retrospective review of the Consortium on Safe Labor electronic database from 2002�2008; women with a prior cesarean birth, desiring TOLAC, and requiring induction of labor were included. Oxytocin and Foley bulb induction methods were compared to amniotomy alone. Prostaglandin use was also reviewed but, given the small numbers, was not the focus of this study.RESULTS: Univariate analysis showed significantly greater incidence of hemorrhage >1,000 mL (p=0.0030) and transfusion (p=0.0076) with Foley bulb use. All methods of induction for TOLAC decreased repeat cesarean sections (OR 0.34, 95% CI 0.23�0.52, p<0.01).CONCLUSION: Induction of labor does not alter the success rate for TOLAC candidates, regardless of mode of induction. When choosing induction methods, one should be mindful of the apparent additional risk of increased blood loss and transfusion with intracervical Foley bulb usage.

目的:探讨不同引产方式对剖宫产后试产(TOLAC)产妇成功率及围产儿发病率的影响。研究设计:2002 - 2008年安全劳动联盟电子数据库的回顾性分析;既往有剖宫产史,希望进行TOLAC,需要引产的妇女也包括在内。催产素和Foley球诱导法与单独羊膜切开法比较。前列腺素的使用也进行了回顾,但由于人数较少,这不是本研究的重点。结果:单因素分析显示,使用Foley球后出血>1,000 mL (p=0.0030)和输血(p=0.0076)的发生率显著增加。所有诱导TOLAC的方法都减少了重复剖宫产(OR 0.34, 95% CI 0.23 ~ 0.52, p
{"title":"Do Different Modes of Labor Induction Affect the Overall Success and Risk of Trial of Labor After Cesarean Section?","authors":"Heidi K Leftwich,&nbsp;Weihua Gao,&nbsp;Judith U Hibbard","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>OBJECTIVE: To determine whether different modes of labor induction impact the success rate and perinatal morbidity in women undergoing trial of labor after cesarean (TOLAC).\u0000\u0000STUDY DESIGN: Retrospective review of the Consortium on Safe Labor electronic database from 2002�2008; women with a prior cesarean birth, desiring TOLAC, and requiring induction of labor were included. Oxytocin and Foley bulb induction methods were compared to amniotomy alone. Prostaglandin use was also reviewed but, given the small numbers, was not the focus of this study.\u0000\u0000RESULTS: Univariate analysis showed significantly greater incidence of hemorrhage >1,000 mL (p=0.0030) and transfusion (p=0.0076) with Foley bulb use. All methods of induction for TOLAC decreased repeat cesarean sections (OR 0.34, 95% CI 0.23�0.52, p<0.01).\u0000\u0000CONCLUSION: Induction of labor does not alter the success rate for TOLAC candidates, regardless of mode of induction. When choosing induction methods, one should be mindful of the apparent additional risk of increased blood loss and transfusion with intracervical Foley bulb usage.</p>","PeriodicalId":50063,"journal":{"name":"生殖医学杂志","volume":"62 1-2","pages":"9-14"},"PeriodicalIF":0.2,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36306915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Levonorgestrel Intrauterine System on Patients with Female Sexual Dysfunction. 左炔诺孕酮宫内系统对女性性功能障碍患者的影响。
IF 0.2 4区 医学 Q4 Medicine Pub Date : 2017-01-01
Mustafa Ulubay, Mustafa Ozturk, Fahri Burcin Firatligil, Ulas Fidan, Riza Efendi Karaca, Mufit Cemal Yenen

OBJECTIVE: To examine the effects of a levonorgestrel-releasing intrauterine device (LID) in patients with female sexual dysfunction and who were using this device for contraception.STUDY DESIGN: The results before device application and at the 6-month follow-up were compared using the female sexual function index (FSFI) test on a sample of 36 patients with female sexual dysfunction who had requested the use of the LID for contraception.RESULTS: The FSFI scores before the placement of an LID and at 6-month follow-up were determined to be 19.3±4.8 and 21.1±3.8 (p<0.001), respectively. In addition, the visual analog scale scores and menstruation duration were determined to be statistically significantly different before and after placement. When the FSFI subgroup evaluations were performed, the desire and arousal parameters before and after the application were determined to be statistically significantly different.CONCLUSION: The use of an LID for contraception resulted in positive effects in patients with female sexual dysfunction.

目的:探讨左炔诺孕酮释放宫内节育器(LID)在女性性功能障碍患者中的应用效果。研究设计:对36例要求使用LID避孕的女性性功能障碍患者进行女性性功能指数(FSFI)测试,比较器械应用前和6个月随访时的结果。结果:在放置LID前和随访6个月时,FSFI评分分别为19.3±4.8和21.1±3.8 (p < 0.05)
{"title":"Effects of Levonorgestrel Intrauterine System on Patients with Female Sexual Dysfunction.","authors":"Mustafa Ulubay,&nbsp;Mustafa Ozturk,&nbsp;Fahri Burcin Firatligil,&nbsp;Ulas Fidan,&nbsp;Riza Efendi Karaca,&nbsp;Mufit Cemal Yenen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>OBJECTIVE: To examine the effects of a levonorgestrel-releasing intrauterine device (LID) in patients with female sexual dysfunction and who were using this device for contraception.\u0000\u0000STUDY DESIGN: The results before device application and at the 6-month follow-up were compared using the female sexual function index (FSFI) test on a sample of 36 patients with female sexual dysfunction who had requested the use of the LID for contraception.\u0000\u0000RESULTS: The FSFI scores before the placement of an LID and at 6-month follow-up were determined to be 19.3±4.8 and 21.1±3.8 (p<0.001), respectively. In addition, the visual analog scale scores and menstruation duration were determined to be statistically significantly different before and after placement. When the FSFI subgroup evaluations were performed, the desire and arousal parameters before and after the application were determined to be statistically significantly different.\u0000\u0000CONCLUSION: The use of an LID for contraception resulted in positive effects in patients with female sexual dysfunction.</p>","PeriodicalId":50063,"journal":{"name":"生殖医学杂志","volume":"62 1-2","pages":"26-30"},"PeriodicalIF":0.2,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36306917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Connexin43 in Cumulus Cells Between Poor and Non-Poor Responders Undergoing in Vitro Fertilization. 体外受精不良应答者与非不良应答者间积云细胞连接蛋白43的比较。
IF 0.2 4区 医学 Q4 Medicine Pub Date : 2017-01-01
Yangyang Zhang, Yang Xu, Qing Xue, Yanrong Kuai, Sheng Wang, Jing Shang

OBJECTIVE: To detect expression of connexin43 in cumulus cells and compare the differences between poor and non-poor ovarian responders undergoing in vitro fertilization (IVF), and to determinate whether the expression of connexin43 correlates with pregnancy outcome.STUDY DESIGN: A total of 152 infertile women undergoing IVF were included in this study. Patients were divided into 2 groups: poor ovarian responders and non-poor ovarian responders. Cumulus cells were collected from oocytes and were analyzed by Western blot for connexin43. Meanwhile, clinical data were obtained.RESULTS: The incidence of poor ovarian response was 18.42% (28/152). Connexin43 was detected in the cumulus cells of all the patients. The relative quantity of connexin43 in the poor responder group (1.11 [0.34, 2.11]) was much lower than that of the non-poor responder group (2.68 [1.41, 4.96]). There was significant difference in connexin43 between pregnant women and non-pregnant women. When adjusting for ovarian response, it yielded similar results.CONCLUSION: Expression of gap junction protein correlates with quantity of oocytes retrieved and might be related to pregnancy outcome. This study suggests that lack of connexin43 expression may contribute to poor ovarian response.

目的:检测子宫积云细胞中connexin43的表达,比较体外受精(IVF)应答不良和非应答不良的卵巢积云细胞中connexin43的表达差异,并确定connexin43的表达是否与妊娠结局相关。研究设计:本研究共纳入152名接受体外受精的不孕妇女。患者分为卵巢不良反应组和非卵巢不良反应组。从卵母细胞中收集积云细胞,用Western blot检测连接蛋白43的表达。同时,获得临床资料。结果:卵巢不良反应发生率为18.42%(28/152)。所有患者的积云细胞中均检测到Connexin43。应答不良组connexin43的相对数量为1.11[0.34,2.11],远低于非应答不良组(2.68[1.41,4.96])。孕妇和非孕妇的连接指数有显著差异。当调整卵巢反应时,也得到了类似的结果。结论:间隙连接蛋白的表达与取卵量有关,可能与妊娠结局有关。这项研究表明,缺乏connexin43的表达可能导致卵巢反应不良。
{"title":"Comparison of Connexin43 in Cumulus Cells Between Poor and Non-Poor Responders Undergoing in Vitro Fertilization.","authors":"Yangyang Zhang,&nbsp;Yang Xu,&nbsp;Qing Xue,&nbsp;Yanrong Kuai,&nbsp;Sheng Wang,&nbsp;Jing Shang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>OBJECTIVE: To detect expression of connexin43 in cumulus cells and compare the differences between poor and non-poor ovarian responders undergoing in vitro fertilization (IVF), and to determinate whether the expression of connexin43 correlates with pregnancy outcome.\u0000\u0000STUDY DESIGN: A total of 152 infertile women undergoing IVF were included in this study. Patients were divided into 2 groups: poor ovarian responders and non-poor ovarian responders. Cumulus cells were collected from oocytes and were analyzed by Western blot for connexin43. Meanwhile, clinical data were obtained.\u0000\u0000RESULTS: The incidence of poor ovarian response was 18.42% (28/152). Connexin43 was detected in the cumulus cells of all the patients. The relative quantity of connexin43 in the poor responder group (1.11 [0.34, 2.11]) was much lower than that of the non-poor responder group (2.68 [1.41, 4.96]). There was significant difference in connexin43 between pregnant women and non-pregnant women. When adjusting for ovarian response, it yielded similar results.\u0000\u0000CONCLUSION: Expression of gap junction protein correlates with quantity of oocytes retrieved and might be related to pregnancy outcome. This study suggests that lack of connexin43 expression may contribute to poor ovarian response.</p>","PeriodicalId":50063,"journal":{"name":"生殖医学杂志","volume":"62 1-2","pages":"50-4"},"PeriodicalIF":0.2,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36307841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conservative Treatment for Patients with Carcinoma in Situ-Positive Margins After a Loop Electroexcisional Procedure: Is It Safe? 环形电切术后原位阳性切缘癌的保守治疗:安全吗?
IF 0.2 4区 医学 Q4 Medicine Pub Date : 2017-01-01
Gun Oh Chong, Yoon Hee Lee, Yoon Soon Lee, Young Lae Cho, Ji Young Park, Dae Gy Hong

OBJECTIVE: To investigate the clinical significance of and appropriate treatments for carcinoma in situ (CIS)-positive margin after a loop electroexcisional procedure (LEEP) in the management of squamous carcinoma in situ (SCIS), adenocarcinoma in situ (ACIS), and microinvasive carcinoma (MIC).STUDY DESIGN: We analyzed 232 patients who underwent a hysterectomy for CIS-positive margin. We investigated the relationship between residual lesions after hysterectomy and clinical parameters, including age, LEEP method, histologic grade of conized cervix, location of the positive margin after LEEP, results of endocervical curettage (ECC), and size of the conized specimen.RESULTS: Age, LEEP method, proximal endocervical margin positivity, and ECC positivity differed significantly between patients with residual lesions and those with no residual lesions. In a comparison between groups with residual disease of a higher or lower grade than MIC, age, LEEP method, ECC positivity, and histologic grade of conized cervix were significantly different. Age, histologic grade of conized cervix, and ECC positivity were clinical parameters significantly contributing to invasive residual lesion in multivariate regression analysis. There were no residual invasive (MIC or advanced invasive cancer) lesions observed in women <50 years old who had SCIS conized lesions after hysterectomy.CONCLUSION: Conservative treatment with close follow-up or reconization for women <50 years old who have conized SCIS lesions without ECC positivity is acceptable. However, this study does not present sufficient evidence for the conservative treatment of conized ACIS or MIC lesions with CIS-positive margins.

目的:探讨环电切除手术(LEEP)后原位癌(CIS)阳性切缘在鳞状原位癌(SCIS)、原位腺癌(ACIS)和微创癌(MIC)治疗中的临床意义和适当治疗方法。研究设计:我们分析了232例因cis阳性切缘而行子宫切除术的患者。我们研究了子宫切除术后残留病变与临床参数的关系,包括年龄、LEEP方法、锥形宫颈的组织学分级、LEEP后阳性边缘的位置、宫颈内膜刮除(ECC)结果和锥形标本的大小。结果:有无残留病变患者年龄、LEEP方法、宫颈近端缘阳性、ECC阳性差异有统计学意义。在MIC以上或以下残余病变组的比较中,年龄、LEEP方法、ECC阳性、锥形宫颈组织学分级差异有统计学意义。多因素回归分析显示,年龄、宫颈锥状病变组织学分级、ECC阳性是影响宫颈浸润性残留病变的重要临床参数。在女性中未观察到残留的侵袭性(MIC或晚期浸润性癌)病变
{"title":"Conservative Treatment for Patients with Carcinoma in Situ-Positive Margins After a Loop Electroexcisional Procedure: Is It Safe?","authors":"Gun Oh Chong,&nbsp;Yoon Hee Lee,&nbsp;Yoon Soon Lee,&nbsp;Young Lae Cho,&nbsp;Ji Young Park,&nbsp;Dae Gy Hong","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>OBJECTIVE: To investigate the clinical significance of and appropriate treatments for carcinoma in situ (CIS)-positive margin after a loop electroexcisional procedure (LEEP) in the management of squamous carcinoma in situ (SCIS), adenocarcinoma in situ (ACIS), and microinvasive carcinoma (MIC).\u0000\u0000STUDY DESIGN: We analyzed 232 patients who underwent a hysterectomy for CIS-positive margin. We investigated the relationship between residual lesions after hysterectomy and clinical parameters, including age, LEEP method, histologic grade of conized cervix, location of the positive margin after LEEP, results of endocervical curettage (ECC), and size of the conized specimen.\u0000\u0000RESULTS: Age, LEEP method, proximal endocervical margin positivity, and ECC positivity differed significantly between patients with residual lesions and those with no residual lesions. In a comparison between groups with residual disease of a higher or lower grade than MIC, age, LEEP method, ECC positivity, and histologic grade of conized cervix were significantly different. Age, histologic grade of conized cervix, and ECC positivity were clinical parameters significantly contributing to invasive residual lesion in multivariate regression analysis. There were no residual invasive (MIC or advanced invasive cancer) lesions observed in women <50 years old who had SCIS conized lesions after hysterectomy.\u0000\u0000CONCLUSION: Conservative treatment with close follow-up or reconization for women <50 years old who have conized SCIS lesions without ECC positivity is acceptable. However, this study does not present sufficient evidence for the conservative treatment of conized ACIS or MIC lesions with CIS-positive margins.</p>","PeriodicalId":50063,"journal":{"name":"生殖医学杂志","volume":"62 1-2","pages":"37-44"},"PeriodicalIF":0.2,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36305815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
生殖医学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1